Global Paclitaxel Injection Market Professional Survey Report 2018

Description

This report studies the global Paclitaxel Injection market status and forecast, categorizes the global Paclitaxel Injection market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.

In recent years, the growing population and increasing disease incidence of ovarian cancer, breast cancer and other cancers drive the global paclitaxel injection industry developing.

In the past five years from 2010-2014, global paclitaxel injection industry developed fast with a larger than 15% annual production growth rate. In China, due to the late start, the production growth rate is 12%~17%, which is a little lower than global average.

In the next few years, with the growing attention on women cancers from the whole society and much larger investment on R&D of paclitaxel injection, this industry will continue developing at a high speed. What's more, because of the high gross profit of producing and selling paclitaxel injection, more and more investors will enter into this industry.

At present, the production of paclitaxel injection mainly concentrated in US, China and EU, the three regions produced about 77.30% of the global total products. Of those, US are the largest production region with a 42.69% of global production market share.

In the future, with the expanded capacity of paclitaxel injection, the manufacturers will face the high risk of price and gross margin decline.

The global Paclitaxel Injection market is valued at 2180 million US$ in 2017 and will reach 4560 million US$ by the end of 2025, growing at a CAGR of 11.1% during 2018-2025.

The major manufacturers covered in this report
Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Drug Strength
Raw meterial Paclitaxel API source

By Application, the market can be split into
Ovarian cancer
Breast cancer
Cervical cancer
Pancreatic cancer
Other

The study objectives of this report are:
To analyze and study the global Paclitaxel Injection capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Paclitaxel Injection manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Paclitaxel Injection are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Paclitaxel Injection Manufacturers
Paclitaxel Injection Distributors/Traders/Wholesalers
Paclitaxel Injection Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch Medical offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Paclitaxel Injection market, by end-use.
Detailed analysis and profiles of additional market players.

TABLE OF CONTENT

Table of Contents

Global Paclitaxel Injection Market Professional Survey Report 2018
1 Industry Overview of Paclitaxel Injection
1.1 Definition and Specifications of Paclitaxel Injection
1.1.1 Definition of Paclitaxel Injection
1.1.2 Specifications of Paclitaxel Injection
1.2 Classification of Paclitaxel Injection
1.2.1 Drug Strength
1.2.2 Raw meterial Paclitaxel API source
1.3 Applications of Paclitaxel Injection
1.3.1 Ovarian cancer
1.3.2 Breast cancer
1.3.3 Cervical cancer
1.3.4 Pancreatic cancer
1.3.5 Other
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India

2 Manufacturing Cost Structure Analysis of Paclitaxel Injection
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Paclitaxel Injection
2.3 Manufacturing Process Analysis of Paclitaxel Injection
2.4 Industry Chain Structure of Paclitaxel Injection

3 Technical Data and Manufacturing Plants Analysis of Paclitaxel Injection
3.1 Capacity and Commercial Production Date of Global Paclitaxel Injection Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Paclitaxel Injection Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Paclitaxel Injection Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Paclitaxel Injection Major Manufacturers in 2017

4 Global Paclitaxel Injection Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Paclitaxel Injection Capacity and Growth Rate Analysis
4.2.2 2017 Paclitaxel Injection Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Paclitaxel Injection Sales and Growth Rate Analysis
4.3.2 2017 Paclitaxel Injection Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Paclitaxel Injection Sales Price
4.4.2 2017 Paclitaxel Injection Sales Price Analysis (Company Segment)

5 Paclitaxel Injection Regional Market Analysis
5.1 North America Paclitaxel Injection Market Analysis
5.1.1 North America Paclitaxel Injection Market Overview
5.1.2 North America 2013-2018E Paclitaxel Injection Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Paclitaxel Injection Sales Price Analysis
5.1.4 North America 2017 Paclitaxel Injection Market Share Analysis
5.2 Europe Paclitaxel Injection Market Analysis
5.2.1 Europe Paclitaxel Injection Market Overview
5.2.2 Europe 2013-2018E Paclitaxel Injection Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2013-2018E Paclitaxel Injection Sales Price Analysis
5.2.4 Europe 2017 Paclitaxel Injection Market Share Analysis
5.3 China Paclitaxel Injection Market Analysis
5.3.1 China Paclitaxel Injection Market Overview
5.3.2 China 2013-2018E Paclitaxel Injection Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2013-2018E Paclitaxel Injection Sales Price Analysis
5.3.4 China 2017 Paclitaxel Injection Market Share Analysis
5.4 Japan Paclitaxel Injection Market Analysis
5.4.1 Japan Paclitaxel Injection Market Overview
5.4.2 Japan 2013-2018E Paclitaxel Injection Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2013-2018E Paclitaxel Injection Sales Price Analysis
5.4.4 Japan 2017 Paclitaxel Injection Market Share Analysis
5.5 Southeast Asia Paclitaxel Injection Market Analysis
5.5.1 Southeast Asia Paclitaxel Injection Market Overview
5.5.2 Southeast Asia 2013-2018E Paclitaxel Injection Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2013-2018E Paclitaxel Injection Sales Price Analysis
5.5.4 Southeast Asia 2017 Paclitaxel Injection Market Share Analysis
5.6 India Paclitaxel Injection Market Analysis
5.6.1 India Paclitaxel Injection Market Overview
5.6.2 India 2013-2018E Paclitaxel Injection Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Paclitaxel Injection Sales Price Analysis
5.6.4 India 2017 Paclitaxel Injection Market Share Analysis

6 Global 2013-2018E Paclitaxel Injection Segment Market Analysis (by Type)
6.1 Global 2013-2018E Paclitaxel Injection Sales by Type
6.2 Different Types of Paclitaxel Injection Product Interview Price Analysis
6.3 Different Types of Paclitaxel Injection Product Driving Factors Analysis
6.3.1 Drug Strength Growth Driving Factor Analysis
6.3.2 Raw meterial Paclitaxel API source Growth Driving Factor Analysis

7 Global 2013-2018E Paclitaxel Injection Segment Market Analysis (by Application)
7.1 Global 2013-2018E Paclitaxel Injection Consumption by Application
7.2 Different Application of Paclitaxel Injection Product Interview Price Analysis
7.3 Different Application of Paclitaxel Injection Product Driving Factors Analysis
7.3.1 Ovarian cancer of Paclitaxel Injection Growth Driving Factor Analysis
7.3.2 Breast cancer of Paclitaxel Injection Growth Driving Factor Analysis
7.3.3 Cervical cancer of Paclitaxel Injection Growth Driving Factor Analysis
7.3.4 Pancreatic cancer of Paclitaxel Injection Growth Driving Factor Analysis
7.3.5 Other of Paclitaxel Injection Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Paclitaxel Injection
8.1 Bristol-Myers Squibb
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Bristol-Myers Squibb 2017 Paclitaxel Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Bristol-Myers Squibb 2017 Paclitaxel Injection Business Region Distribution Analysis
8.2 Celgene Corporation
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Celgene Corporation 2017 Paclitaxel Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Celgene Corporation 2017 Paclitaxel Injection Business Region Distribution Analysis
8.3 Hospira
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Hospira 2017 Paclitaxel Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Hospira 2017 Paclitaxel Injection Business Region Distribution Analysis
8.4 Biological E.
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Biological E. 2017 Paclitaxel Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Biological E. 2017 Paclitaxel Injection Business Region Distribution Analysis
8.5 Taj Accura
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Taj Accura 2017 Paclitaxel Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Taj Accura 2017 Paclitaxel Injection Business Region Distribution Analysis
8.6 Khandelwal Laboratories
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Khandelwal Laboratories 2017 Paclitaxel Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Khandelwal Laboratories 2017 Paclitaxel Injection Business Region Distribution Analysis
8.7 Luye Pharma
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Luye Pharma 2017 Paclitaxel Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Luye Pharma 2017 Paclitaxel Injection Business Region Distribution Analysis
8.8 Beijing Youcare
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Beijing Youcare 2017 Paclitaxel Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Beijing Youcare 2017 Paclitaxel Injection Business Region Distribution Analysis
8.9 Beijing Union
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Beijing Union 2017 Paclitaxel Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Beijing Union 2017 Paclitaxel Injection Business Region Distribution Analysis
8.10 Haiyao
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Haiyao 2017 Paclitaxel Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Haiyao 2017 Paclitaxel Injection Business Region Distribution Analysis
8.11 Chuntch

9 Development Trend of Analysis of Paclitaxel Injection Market
9.1 Global Paclitaxel Injection Market Trend Analysis
9.1.1 Global 2018-2025 Paclitaxel Injection Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Paclitaxel Injection Sales Price Forecast
9.2 Paclitaxel Injection Regional Market Trend
9.2.1 North America 2018-2025 Paclitaxel Injection Consumption Forecast
9.2.2 Europe 2018-2025 Paclitaxel Injection Consumption Forecast
9.2.3 China 2018-2025 Paclitaxel Injection Consumption Forecast
9.2.4 Japan 2018-2025 Paclitaxel Injection Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Paclitaxel Injection Consumption Forecast
9.2.6 India 2018-2025 Paclitaxel Injection Consumption Forecast
9.3 Paclitaxel Injection Market Trend (Product Type)
9.4 Paclitaxel Injection Market Trend (Application)

10 Paclitaxel Injection Marketing Type Analysis
10.1 Paclitaxel Injection Regional Marketing Type Analysis
10.2 Paclitaxel Injection International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Paclitaxel Injection by Region
10.4 Paclitaxel Injection Supply Chain Analysis

11 Consumers Analysis of Paclitaxel Injection
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Paclitaxel Injection Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source

Choose License Type

Checkout Inquiry